Literature DB >> 21881360

Intrapulmonary-located Castleman's disease, which was surgically resected without pulmonary resection.

Gulsah Gunluoglu1, Aysun Olcmen, Sinem Nedime Sokucu, Hasan Akin, Ibrahim Dincer.   

Abstract

Castleman's disease (CD) is a rare disease with unknown aetiology. It is characterised by benign lymph node hyperplasia that may involve all lymph nodes. The most common locations are the mediastinum and abdomen. CD arising from intrapulmonary lymph nodes has been reported in five cases, in the English language literature to date. Tumours in these patients are usually resected during lung surgery. An asymptomatic 29-year-old male patient was evaluated due to a mass lesion with a diameter of 55 mm located in the infrahilar region of the right lung with a high degree of contrast enhancement on thoracic computed tomography (CT). Vascularity of this central lesion was excluded by pulmonary angiography. Thoracotomy was performed due to the inability to obtain a diagnosis with percutaneous fine needle aspiration biopsies. A frozen section examination of the mass revealed a benign lesion, arising from the intrapulmonary lymph nodes and protruding to the lower-lobe parenchyma. The mass was then extracted from the parenchyma. After histopathological evaluation of the mass, CD involving the lymph nodes was diagnosed. CD rarely involves the intrapulmonary lymph nodes. Diagnosis is difficult in these patients, and thoracotomy may be required. After obtaining benign results by mass sampling, limited resection of these masses, while sparing the lung parenchyma, may be possible.

Entities:  

Mesh:

Year:  2011        PMID: 21881360     DOI: 10.5761/atcs.cr.10.01644

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  8 in total

1.  Unicentric Castleman's disease: an uncommon cause of posterior mediastinal mass.

Authors:  Aliasghar Alavi; Mehrnaz Asadi Gharabaghi
Journal:  BMJ Case Rep       Date:  2013-06-11

2.  Intrapulmonary unicentric Castleman disease mimicking peripheral pulmonary malignancy.

Authors:  Yi Liu; Gang Chen; Xiaoming Qiu; Song Xu; Yi Wu; Renwang Liu; Qinghua Zhou; Jun Chen
Journal:  Thorac Cancer       Date:  2014-10-23       Impact factor: 3.500

Review 3.  Clinicopathological comparison and therapeutic approach to Castleman disease-a case-based review.

Authors:  Małgorzata Wojtyś; Agnieszka Piekarska; Michał Kunc; Konrad Ptaszyński; Wojciech Biernat; Jan Maciej Zaucha; Piotr Waloszczyk; Piotr Lisowski; Bartosz Kubisa; Tomasz Grodzki
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

4.  Intrapulmonary Castleman's Disease Pretending to Be a Lung Cancer-Work Up of an Intrapulmonary Tumour.

Authors:  Benedikt Haager; Gian Kayser; Severin Schmid; Bernward Passlick; Sebastian Wiesemann
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-11-19       Impact factor: 1.520

5.  Clinical spectrum of intrathoracic Castleman disease: a retrospective analysis of 48 cases in a single Chinese hospital.

Authors:  Jin Mei Luo; Shan Li; Hui Huang; Jian Cao; Kai Xu; Ya Lan Bi; Rui E Feng; Cheng Huang; Ying Zhi Qin; Zuo Jun Xu; Yi Xiao
Journal:  BMC Pulm Med       Date:  2015-04-09       Impact factor: 3.317

6.  Tumor enucleation for Castleman's disease in the pulmonary hilum: a case report.

Authors:  Masaya Aoki; Go Kamimura; Tadashi Umehara; Aya Harada Takeda; Yui Watanabe; Koki Maeda; Toshiyuki Nagata; Tsunayuki Otsuka; Masami Sato
Journal:  Surg Case Rep       Date:  2019-06-10

7.  Amyloidosis secondary to intrapulmonary Castleman disease mimicking pulmonary hyalinizing granuloma-like clinical features: A rare case report.

Authors:  Shao-Ting Wang; Qi-Pu Wang; Ji Li; Ting Zhang; Lu Zhang; Yue-Ying Mao
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

8.  Unicentric Castleman's Disease Arising from an Intrapulmonary Lymph Node.

Authors:  Hideki Ota; Hideki Kawai; Tsubasa Matsuo
Journal:  Case Rep Surg       Date:  2013-06-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.